Pneumonia

Pneumonia is recruiting two new Editors-in-Chief.

View job description here

Guest edited by Professor Ben Marais (University of Sydney, Australia), this series of articles provides an overview of the global child tuberculosis burden and examines issues such as diagnosis, advances in treatment, and novel vaccination approaches. The series aims to address the needs of researchers, clinicians and other individuals who require up-to-date information on this topic.

Pneumonia is pleased to be still accepting submissions for this thematic series.

Read more

World TB Day, which falls on March 24th each year, is organised by the World Health Organisation with the aim to raise public awareness of the devastating consequences of tuberculosis (TB) and the on-going efforts to end the global TB epidemic. To mark the occasion, we have discussed TB with Dr James Seddon, who has published a highly-accessed review about drug-resistant TB and advances in the treatment of childhood TB in our journal Pneumonia.

Read the blog here

The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced to prevent invasive pneumococcal disease (IPD) in Western Australian (WA) Aboriginal people in 2001. PCV13 replaced PCV7 in July 2011, covering six additional pneumococcal serotypes; however, IPD rates remained high in Aboriginal people in WA. Upper respiratory tract pneumococcal carriage can precede IPD, and PCVs alter serotype distribution. This study describes the prevalence of overall carriage and that of individual serotypes in the WA Aboriginal population before and after the introduction of PCV13, along with epidemiological risk factors for carriage.

Read the article